Chemours Settles North Carolina PFAS Claims for $455M, Resolving Major Legacy Liability
CC sits 44% above its 52-week low of $10.44.
Summary
Chemours, along with DuPont and Corteva, reached a $455 million settlement with North Carolina and 11 local entities to resolve PFAS-related claims from the Fayetteville Works facility and other contamination. Chemours' share is 50%, approximately $180 million on a net present value basis, with about $50 million due in the next 12 months. The settlement is covered by existing accruals, so no new earnings hit is expected. This follows the June 2026 EPA/West Virginia settlement and provides clarity on a major legacy liability, reducing uncertainty around the company's environmental exposure. The agreement also eliminates future MOU escrow contributions, including a $50 million payment that would have been due this month. This is a significant step in resolving Chemours' PFAS litigation overhang, which has weighed on the stock given the company's negative equity and large environmental reserves.
At the time of this announcement, CC was trading at $15.08 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $10.44 to $28.67. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.